Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Tien En Chang"'
Autor:
Kai-Liang Lin, Kuan-Yi Sung, Yong-Cheng Ye, Yen-Po Wang, Tien-En Chang, Pei-Shan Wu, Jiing-Chyuan Luo, Ming-Chih Hou, Ching-Liang Lu
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Capsule endoscopy (CE) is useful for managing patients with suspected small bowel diseases. However, the effect of prolonged CE examination time on CE performance is unknown. Aim To evaluate the completeness and diagnostic yield o
Externí odkaz:
https://doaj.org/article/8cd719fb0dca40d5a0e2b7f47d3d5d06
Autor:
Tien‐En Chang, Kuei‐Chuan Lee, Pei‐Chang Lee, Yen‐Po Wang, Yi‐Tsung Lin, Hui‐Chun Huang, Jiing‐Chyuan Luo, Hsiang‐Ling Ho, Yi‐Hsiang Huang, Ming‐Chih Hou, Task Force for Precision Medicine in Gut Microbial Therapy
Publikováno v:
JGH Open, Vol 7, Iss 11, Pp 765-771 (2023)
Abstract Background and Aim Fecal microbiota transplantation (FMT) is used to treat recurrent or refractory Clostridioides difficile infection (CDI). In the past, screening of fecal donors required surveillance of personal behavior, medical history,
Externí odkaz:
https://doaj.org/article/e6a48d959a444d81bbb631578a2adaa0
Autor:
Pei-Chang Lee, Tien-En Chang, Yen-Po Wang, Kuei-Chuan Lee, Yi-Tsung Lin, Jen-Jie Chiou, Chi-Wei Huang, Ueng-Cheng Yang, Fen-Yau Li, Hui-Chun Huang, Chun-Ying Wu, Yi-Hsiang Huang, Ming-Chih Hou
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 9, Pp 1636-1646 (2022)
Background/purpose: Clostridium difficile infection (CDI) leads to a significant cause of hospital-acquired morbidity and mortality. Fecal microbiota transplantation (FMT) is effective to treat recurrent or refractory CDI (rCDI). However, the change
Externí odkaz:
https://doaj.org/article/7e4c58a81d9d49ad9b97cc30b6e3f516
Autor:
Chia-Ju Li, Tien-En Chang, Ming-Chih Hou, Yi-Hsiang Huang, Pei-Chang Lee, Nai-Wen Chang, Yu-Jen Chen, Fa-Yuah Lee
Publikováno v:
Journal of the Chinese Medical Association. 86:147-154
Autor:
Kuan-Yi, Sung, Tien-En, Chang, Yen-Po, Wang, Chun-Chi, Lin, Chung-Yu, Chang, Ming-Chih, Hou, Ching-Liang, Lu
Publikováno v:
Journal of the Chinese Medical Association. 85:421-430
In the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination has been effective in preventing COVID-19 infections and related mortality. The SARS-CoV-2 vaccination was also recommended
Autor:
Kuan-I Sung, Fa-Yauh Lee, Huann Sheng Wang, Jeng-Kai Jiang, Ming-Chih Hou, Yen-Po Wang, Jiing-Chyuan Luo, Ching Liang Lu, Tien-En Chang
Publikováno v:
Journal of the Chinese Medical Association. 85:304-310
BACKGROUND With the growth of the aging population, the need for colonoscopies in nonagenarians is rising. However, few data on colonoscopies in extremely elderly individuals are available. To better acknowledge the role of colonoscopies in this spec
Publikováno v:
Journal of the Chinese Medical Association. 84:129-135
Background Hyperbilirubinemia is a predictor of severe drug-induced liver injury (DILI). Hepatobiliary ATP-binding cassette (ABC) transporters play an important role in the transportation of many drugs and bilirubin; however, little is known about th
Publikováno v:
Journal of the Chinese Medical Association. 84:14-18
Background Nonalcoholic steatohepatitis (NASH) is closely related to reactive oxygen species (ROS). Superoxide anion radicals, the main product of ROS, can be reduced by manganese superoxide dismutase (SOD2) to hydrogen peroxide, which is further red
Publikováno v:
Journal of the Chinese Medical Association : JCMA. 85(1)
Hepatitis delta virus (HDV) is a defective virus that relies on the supply of hepatitis B surface antigen (HBsAg) from hepatitis B virus (HBV) to assemble HDV virions and infect hepatocytes. However, controversy remains in whether the presence of HDV
Publikováno v:
Journal of the Chinese Medical Association : JCMA. 84(11)
BACKGROUND The mainstay therapy for latent tuberculosis infection is a 9-month regimen of daily isoniazid (9H) and a 3-month regimen of 12 once-weekly doses of isoniazid and rifapentine (3HP). We performed this updated meta-analysis to compare hepato